Pfizer and Arvinas are poised to bring the third oral selective oestrogen receptor degrader (SERD) to market in the US, after ...
The U.S. Food and Drug Administration on Friday approved Pfizer and Arvinas' breast cancer drug for patients with an ...
Belgian biotech UCB has made its second acquisition of the year, agreeing a front-loaded takeover of US biotech Candid ...
The health news this week highlights key legal and medical developments. Danco Laboratories is challenging a court's decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results